SIGMA Brand
Displaying 152551-152600 of 159568 results.
| Sigma Cat.No. | Description |
|---|---|
| V3501 | Vitamin K1 viscous liquid |
| V3628 | Vasoactive Intestinal Peptide human, porcine, rat ≥95% (HPLC), powder |
| V3638 | Vascular Endothelial Growth Factor 164 from rat >95% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder |
| V3639 | Valinomycin Ready Made Solution, ~1 mg/mL in DMSO |
| V3640 | Valpromide ≥97% (NMR) |
| V3765 | VU0255035 hydrate ≥98% (HPLC) |
| V3881 | Freezing vials, natural capacity 1.5 mL, skirted, non-sterile |
| V3890 | VU0240551 ≥98% (HPLC) |
| V4000 | Snake venom from Agkistrodon contortrix laticinctus |
| V4014 | Anti-V5-Cy3™ antibody, Mouse monoclonal purified immunoglobulin, ~1 mg/mL, clone V5-10 |
| V4015 | Verbascoside ≥99% (HPLC) |
| V4131 | Freezing vials, natural capacity 1.5 mL, conical bottom, sterile |
| V4139 | Anti-Vinculin antibody produced in rabbit affinity isolated antibody, buffered aqueous solution |
| V4140 | Virginiamycin S1 ≥99% (HPLC) |
| V4253 | [β-Mercapto-β,β-cyclopentamethylenepropionyl1, O-Et-Tyr2, Val4, Arg8]-Vasopressin ≥97% (HPLC) |
| V4262 | Monoclonal Anti-Vascular Endothelial Growth Factor Receptor-1 antibody produced in mouse clone FLT-11, ascites fluid |
| V4380 | [D-p-Cl-Phe6, Leu17]-Vasoactive Intestinal Peptide human, porcine, rat ≥97% (HPLC) |
| V4381 | Freezing vials, natural capacity 1.5 mL, skirted bottom, sterile |
| V4383 | Vimentin from bovine lens lyophilized powder |
| V4388 | Anti-VP16 antibody produced in rabbit IgG fraction of antiserum, buffered aqueous solution |
| V4389 | Anti-Visual Arrestin antibody produced in rabbit affinity isolated antibody, buffered aqueous solution |
| V4390 | VUF 8430 dihydrobromide ≥97% (NMR) |
| V4505 | Monoclonal Anti-Vinculin antibody produced in mouse clone VIN-11-5, ascites fluid |
| V4507 | Nalgene® cryogenic vials capacity 1.2 mL, non-sterile, External threads |
| V4508 | Vasoactive Intestinal Peptide Fragment 6-28 human, porcine, rat ≥97% (HPLC) |
| V4512 | Vascular Endothelial Growth Factor from mouse VEGF, recombinant, expressed in E. coli, powder, suitable for cell culture |
| V4514 | Anti-Vesicle Associated Membrane Protein 4, (VAMP4) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution |
| V4515 | VU0238429 solubility: ≥20 mg/mL in DMSO |
| V4629 | (±)-Verapamil hydrochloride ≥99% (titration), powder |
| V4630 | Anti-Vimentin antibody produced in goat whole antiserum |
| V4632 | Nalgene® cryogenic vials capacity 2.0 mL, non-sterile |
| V4638 | L-Valine |
| V4640 | VU0357017 monohydrochloride ≥98% (HPLC) |
| V4757 | Nalgene® cryogenic vials capacity 1.2 mL, External threads, sterile; irradiated |
| V4758 | Monoclonal Anti-Vascular Endothelial Growth Factor antibody produced in mouse clone 26503, purified immunoglobulin, lyophilized powder |
| V4762 | Monoclonal Anti-Vascular Endothelial Growth Factor Receptor-1 antibody produced in mouse clone FLT-19, tissue culture supernatant |
| V4765 | Valnoctamide ≥98% (NMR) |
| V4877 | Verrucarin A from Myrothecium sp. ≥85.0% (HPLC) |
| V4881 | Freezing vials, natural capacity 2 mL, skirted bottom, non-sterile |
| V4882 | Nalgene® cryogenic vials capacity 1.2 mL, sterile; irradiated, External threads, pkg of (Bulk packed) |
| V4888 | Anti-VSV-G antibody produced in rabbit affinity isolated antibody, buffered aqueous solution |
| V4889 | Anti- affinity isolated antibody, buffered aqueous solution |
| V4890 | Vindesine sulfate salt hydrate ≥95% (HPLC) |
| V5005 | Freezing vials 2.0 mL, sterile yellow cap |
| V5007 | Nalgene® cryogenic vials capacity 2.0 mL, sterile, External threads |
| V5015 | VU0152100 ≥98% (HPLC) |
| V5131 | Freezing vials, natural conical style, sterile |
| V5132 | Nalgene® cryogenic vials capacity 2.0 mL, sterile, External threads, pkg of (Bulk packed) |
| V5140 | VPS34 human recombinant, expressed in Sf9 cells |
| V5251 | Scorpion venom from Leiurus quinquestriatus (north Africa) |